Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2023 Apr;110(4):414-425.
doi: 10.1111/ejh.13919. Epub 2023 Jan 2.

Efficacy and safety of calcium channel blockers in preventing cardiac siderosis in thalassemia patients: An updated meta-analysis with trial sequential analysis

Youssef Soliman  1   2 , Ahmed Abdelaziz  1   3 , Adel Mouffokes  1   4 , Basma E Amer  1   5 , Yomna Mohamed Goudy  1   6 , Omar Ahmed Abdelwahab  1   3 , Marwa M Badawy  1   7 , Rehab Adel Diab  1   3 , Asmaa Elsharkawy  1   8
Affiliations
Meta-Analysis

Efficacy and safety of calcium channel blockers in preventing cardiac siderosis in thalassemia patients: An updated meta-analysis with trial sequential analysis

Youssef Soliman et al. Eur J Haematol. 2023 Apr.

Abstract

Objectives: Iron overload in patients with thalassemia represents a serious complication by affecting numerous organ systems. This meta-analysis aims to establish an evidence regarding the effect of amlodipine on cardiac iron overload in thalassemia patients.

Methods: We searched PubMed, Scopus, Web of Science, Cochrane Central, and EMBASE for all relevant randomized controlled trials (RCTs). The primary outcomes were cardiac T2* and myocardial iron concentration (MIC). Secondary outcomes were liver iron concentration (LIC), risk of Gastrointestinal (G.I.) upset and risk of lower limb edema. We used Hedges' g to pool continuous outcomes, while odds ratio was used for dichotomous outcomes.

Results: Seven RCTs were eligible for this systematic review and meta-analysis, comprising of 233 patients included in the analysis. Amlodipine had a statistically significant lower MIC (Hedges' g = -0.82, 95% confidence interval [CI] [-1.40, -0.24], p < .001) and higher cardiac T2* (Hedges' g = 0.36, 95% CI [0.10, 0.62], p = .03). Amlodipine was comparable to standard chelation therapy in terms of the risk of lower limb edema and GI upset.

Conclusion: Our meta-analysis found that amlodipine significantly increases cardiac T2* and decreases MIC, hence decreasing the incidence of cardiomyopathy-related iron overload in thalassemia patients.

Keywords: amlodipine; cardiac T2*; iron overload; thalassemia.

PubMed Disclaimer

References

REFERENCES

    1. Viprakasit V, Ekwattanakit S. Clinical classification, screening and diagnosis for thalassemia. Hematol Oncol Clin North Am [Internet]. 2018;32(2):193-211.
    1. Taher AT, Weatherall DJ, Cappellini MD. Thalassaemia. Lancet (London, England). 2018;391(10116):155-167.
    1. Weatherall DJ. The evolving Spectrum of the epidemiology of thalassemia. Hematol Oncol Clin North Am. 2018;32(2):165-175.
    1. Galanello R, Origa R. Beta-thalassemia. Orphanet J Rare Dis. 2010;5(1):11.
    1. Brancaleoni V, Di Pierro E, Motta I, Cappellini MD. Laboratory diagnosis of thalassemia. Int J Lab Hematol. 2016;38(Suppl 1):32-40.

LinkOut - more resources